Pairing targeted drugs for breast and lung cancer could overcome treatment resistance 12 Jul 2019 Targeted drugs for breast and lung cancer could be used together to overcome resistance to treatment in several different tumour types, a new study shows. Find out more Show/Hide
Precision drugs could unmask cancers to the immune system and boost the effects of immunotherapy 09 Mar 2019 Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals. Find out more Show/Hide
New ‘Trojan horse’ cancer treatment shows early promise in multiple tumour types 07 Feb 2019 A brand new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumour cells has shown promise in patients with six different cancer types. Find out more Show/Hide
Blocking energy production could help treat lung cancer where chemotherapy has limited effect 12 Jun 2018
ICR reacts to decision to make the immunotherapy nivolumab available on the Cancer Drugs Fund for non-small cell lung cancers 20 Sep 2017